New incident report
Incident Report Number: 2013-4541
Registrant Reference Number: 2013AM220
Registrant Name (Full Legal Name no abbreviations): Bayer Inc
Address: 77 Belfield Rd
City: Toronto
Prov / State: ON
Country: Canada
Postal Code: M9W 1G6
Domestic Animal
Country: UNITED STATES
Prov / State: UNKNOWN
Unknown
PMRA Registration No. PMRA Submission No. EPA Registration No. 11556
Product Name: K9 Advantix (unknown size)
Liquid
Yes
Unknown
Site: Animal / Usage sur un animal domestique
Animal's Owner
Dog / Chien
Golden Retriever
1
Male
9
Unknown
Skin
Unknown / Inconnu
Unknown / Inconnu
System
Unknown / Inconnu
Unknown
Unknown
Died
Treatment / Traitement
(eg. description of the frequency and severity of the symptoms
On an unknown date in 2010, a 9 year old, male, Retriever (Golden) canine, with an unknown weight, in fair condition, with an unspecified cancer, was administered 1 tube of K9 Advantix (unspecified) (Imidacloprid - Permethrin) once topically by the owner. On an unspecified time after application the dog passed away. A necropsy was not performed.
Death
Limited details were provided for this event. Death is not expected in dogs after product application, as inconsistent with pharmaco-toxicological product profile. Reliability is questionable due to very low level of information (unspecified cancer, time to onset unknown, necropsy not available), as the intent of the phone call to Bayer was to ask question about expiration date on the product and not to report the death of the patient. Other etiologies are more probable, e.g. cancer. No signs of allergy or anaphylactic reaction were reported. Even though time to onset is unknown, occurrence of signs within window of allergic /anaphylactic reaction (within 1 day) are unlikely, as they would have been reported in close proximity. Considering all aspects, product connection deemed to be unlikely.